CINECA IRIS Institutional Research Information System

ELIA, GIUSY
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.588
AS - Asia 2.857
EU - Europa 2.469
SA - Sud America 582
AF - Africa 165
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.674
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.445
IT - Italia 1.050
SG - Singapore 888
CN - Cina 741
BR - Brasile 481
HK - Hong Kong 443
SE - Svezia 392
VN - Vietnam 332
DE - Germania 218
BG - Bulgaria 128
FR - Francia 125
GB - Regno Unito 115
FI - Finlandia 111
RU - Federazione Russa 92
CA - Canada 84
IN - India 80
NL - Olanda 65
IQ - Iraq 56
TR - Turchia 54
JP - Giappone 53
CI - Costa d'Avorio 51
BD - Bangladesh 42
MX - Messico 35
AR - Argentina 34
AT - Austria 29
PL - Polonia 29
SN - Senegal 27
ZA - Sudafrica 23
ES - Italia 22
NG - Nigeria 22
UA - Ucraina 22
KR - Corea 20
SA - Arabia Saudita 19
EC - Ecuador 16
PK - Pakistan 15
CH - Svizzera 14
CO - Colombia 14
ID - Indonesia 14
MA - Marocco 13
PH - Filippine 13
UZ - Uzbekistan 13
PY - Paraguay 11
VE - Venezuela 11
IE - Irlanda 10
AU - Australia 9
CZ - Repubblica Ceca 8
JO - Giordania 8
KE - Kenya 8
GR - Grecia 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
LT - Lituania 6
TH - Thailandia 6
UY - Uruguay 6
BY - Bielorussia 5
IR - Iran 5
PS - Palestinian Territory 5
TN - Tunisia 5
TW - Taiwan 5
AL - Albania 4
KZ - Kazakistan 4
NP - Nepal 4
TT - Trinidad e Tobago 4
CL - Cile 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
GT - Guatemala 3
HN - Honduras 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BJ - Benin 2
BN - Brunei Darussalam 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GY - Guiana 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
PA - Panama 2
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
FJ - Figi 1
GA - Gabon 1
GH - Ghana 1
HR - Croazia 1
Totale 11.660
Salva come PNG Salva come JPEG
Città #
Ashburn 611
Dallas 528
Singapore 525
Fairfield 447
San Jose 433
Hong Kong 431
Santa Clara 392
Woodbridge 264
Milan 231
Chandler 229
Pisa 221
Houston 192
Shanghai 186
Seattle 182
Cambridge 162
Wilmington 147
Serra 145
New York 130
Sofia 128
Ann Arbor 126
Council Bluffs 124
Los Angeles 122
Beijing 112
Ho Chi Minh City 90
Munich 88
Boardman 86
Princeton 82
Helsinki 66
Lauterbourg 55
Lawrence 55
London 55
Rome 53
Abidjan 51
Florence 51
Medford 49
Tokyo 49
Frankfurt am Main 47
Hanoi 44
Redondo Beach 40
São Paulo 37
Hefei 36
Ottawa 33
Buffalo 31
Turku 30
Dong Ket 28
Dakar 27
Istanbul 27
Boulder 26
Des Moines 23
Redwood City 23
San Diego 23
Warsaw 23
Fuzhou 21
Nanjing 21
Bremen 20
Seoul 20
Lagos 19
Baghdad 18
Hyderabad 18
Nuremberg 18
Orem 18
Sulaymaniyah 18
Dearborn 17
Chennai 16
Ogden 16
Paris 16
Rio de Janeiro 16
Vienna 16
Livorno 15
Phoenix 15
Amsterdam 14
Brooklyn 14
Carrara 14
Johannesburg 14
Montreal 14
Da Nang 13
Düsseldorf 13
Haiphong 13
Norwalk 13
The Dalles 13
Guangzhou 12
Quanzhou 12
Tashkent 12
Washington 12
Baltimore 11
Denver 11
Tianjin 11
Changsha 10
Chicago 10
Curitiba 10
Toronto 10
Catania 9
Chengdu 9
Columbus 9
Dublin 9
Hải Dương 9
Manchester 9
Mexico City 9
Zurich 9
Amman 8
Totale 8.050
Salva come PNG Salva come JPEG
Nome #
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 254
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 243
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 236
Molecular testing in the diagnosis of differentiated thyroid carcinomas 225
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 203
Mechanostructure and composition of highly reproducible decellularized liver matrices 200
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 195
Characterisation of liver matrices 190
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 189
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 188
Novel therapies for thyroid autoimmune diseases: An update 188
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 188
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 187
New insight in endocrine-related adverse events associated to immune checkpoint blockade 187
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 182
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 182
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 177
Novel treatments for anaplastic thyroid carcinoma 172
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 169
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 166
Liver derived decellularised matrices in bioreactors 165
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 163
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 163
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 161
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 161
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 161
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 161
Liver decellularised matrices in Quasi-Vivo® bioreactors as in-vitro models of hepatic metabolism 159
Chemokines in thyroid autoimmunity 158
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 156
Immune and inflammatory cells in thyroid cancer microenvironment 156
Novel treatment options for anaplastic thyroid cancer 155
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 155
Thyroid Autoimmunity and SARS-CoV-2 Infection 153
Recent advances in precision medicine for the treatment of anaplastic thyroid cancer 153
Novel Therapies for Thyroid Autoimmune Diseases 149
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 149
The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results 148
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 147
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy 145
The protective effect of myo-inositol on human thyrocytes 144
Chemokines in hyperthyroidism 143
Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer 141
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 141
Antineoplastic effect of doxorubizen in vitro in continuous and primary human anaplastic thyroid cancer cells 141
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 141
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 140
Hypothyroidism and metabolic cardiovascular disease 140
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 140
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose 139
Molecular features of aggressive thyroid cancer 138
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 136
The COVID-19, epidemiology, clinic and prevention 135
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In Vitro 134
Thyroid Metastasis from Primary Breast Cancer 133
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer 133
Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study 132
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups 126
Metastases free thyroid cancer patients harbouring TERT mutations may benefit from a more intensive treatment and follow-up 123
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 123
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 121
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 118
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 118
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review 116
null 115
Teprotumumab for the treatment of thyroid eye disease 114
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 114
Precision Medicine in Graves’ Disease and Ophthalmopathy 113
Endocrine disruptors and thyroid autoimmunity 105
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 104
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 103
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes 103
L-T4 Therapy in Enteric Malabsorptive Disorders 102
High risk of brain tumors in military personnel: a case control study 100
null 87
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 86
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 85
Thyroid autoimmune disorders and cancer 82
Myoinositol in Autoimmune Thyroiditis 74
null 73
Th1 chemokines in autoimmune endocrine disorders 69
COVID-19 AND CRYOGLOBULINEMIC VASCULITIS. LONG-TERM SURVEY STUDY ON THE IMPACT OF PANDEMIC AND VACCINATION ON A LARGE PATIENT'S POPULATION 60
Autoimmune Thyroid Diseases and Epigenetics 32
The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro 26
Nanoparticles in Thyroid Autoimmunity: Diagnostic and Therapeutic Applications 18
Interferon-γ-induced protein 10 in Dengue virus infection 12
Leishmaniasis and IFN-γ dependent chemokines 11
Interferon-γ-Inducible chemokines in Systemic Lupus Erythematosus 11
Dermatomyositis and chemokines 9
MIG Th1 chemokine in Vitiligo 8
MIG in psoriatic arthritis 6
Totale 12.057
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 0 0 109
2021/2022809 17 16 31 49 123 103 32 39 70 66 63 200
2022/2023907 137 128 74 53 74 104 38 53 153 6 67 20
2023/2024968 81 93 137 109 138 155 65 23 14 21 39 93
2024/20252.962 142 86 81 169 273 341 271 152 190 334 335 588
2025/20264.127 278 406 584 405 381 312 620 178 226 474 148 115
Totale 12.057